Harold J. Burstein, MD, PhD
5 clinical trials · Sponsor
◉ Watch Harold J. Burstein, MD, PhD
| Record | Firm | Date |
|---|---|---|
| Bevacizumab in Combination With Vinorelbine and Trastuzumab for HER2-Positive, Metastatic Breast Cancer (NCT00670982) | Harold J. Burstein, MD, PhD | 2008-05-01 |
| Dose Dense Abraxane in Adjuvant Chemotherapy for Breast Cancer (NCT00308178) | Harold J. Burstein, MD, PhD | 2006-03-01 |
| Bevacizumab With or Without Cyclophosphamide and Methotrexate: A Pilot Study in Women With Operable Breast Cancer (NCT00121134) | Harold J. Burstein, MD, PhD | 2005-06-01 |
| Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer (NCT00146562) | Harold J. Burstein, MD, PhD | 2003-07-01 |
| Neoadjuvant Therapy With Herceptin and Taxol for Breast Cancer (NCT00136539) | Harold J. Burstein, MD, PhD | 1999-03-01 |
Track Harold J. Burstein, MD, PhD automatically
Every clearance here is in the API, with alerts when new ones post.